Fundraising Fox
Campfieldtx
2 known investors
Find your way into Campfieldtx
Sign up to see every warm intro you have to Campfieldtx
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Campfieldtx team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
cAMPfield is a clinical-stage biopharmaceutical company developing prifemilast, a once-daily oral PDE4B-selective inhibitor for immune-mediated inflammatory diseases, primarily inflammatory bowel disease (ulcerative colitis and Crohn's disease). The company is advancing the drug into global Phase 2 clinical development.
Founders & leadership
Investors · 2
Frequently asked questions
- What does Campfieldtx do?
- cAMPfield is a clinical-stage biopharmaceutical company developing prifemilast, a once-daily oral PDE4B-selective inhibitor for immune-mediated inflammatory diseases, primarily inflammatory bowel disease (ulcerative colitis and Crohn's disease). The company is advancing the drug into global Phase 2 clinical development.
- Who are Campfieldtx's investors?
- Campfieldtx's investors include Frazier Life Sciences, Longitude Capital.